It’s still early days, and the test was only on 53 people, but a new drug called Trontinemab almost completely eliminated the brain plaques indicative of Alzheimer’s in 91% of them. Wider trials on 1,800 people will take place later this year. Fingers crossed. Alzheimer’s is dreaded by many people; a cure or near-cure would have a major impact.

Roche’s New Alzheimer’s Drug Trontinemab Nearly Eliminates Brain Plaques